Medications and Drugs
Brand Names: NovoSeven RT
Generic Name: coagulation factor VIIa (injection) (Pronunciation: koe AG yoo LAY shun FAK tor)
What is coagulation factor VIIa (NovoSeven RT)?
Coagulation factor VIIa is a man-made protein similar to a natural protein in the body that helps the blood to clot.
Coagulation factor VIIa may also be used for purposes not listed in this medication guide.
What are the possible side effects of coagulation factor VIIa (NovoSeven RT)?
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
Common side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is the most important information I should know about coagulation factor VIIa (NovoSeven RT)?
You should not receive coagulation factor VIIa if you are allergic to it.
If possible before you receive coagulation factor VIIa, tell your doctor about all your medical conditions and allergies. Also make sure your doctor knows if you are pregnant or breast-feeding.
Tell your doctor about all other medications you use to treat or prevent bleeding episodes.
In an emergency situation it may not be possible to tell your caregivers about your health conditions. Make sure any doctor caring for you afterward knows you have received this medicine.
Call your doctor at once if you have sudden numbness or weakness, sudden cough or headache, pain or swelling in one or both legs, chest pain, or problems with vision, speech, or balance.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
- Questions for Your Pediatrician About Hemophilia
- Treatments for Multiple Myeloma
- New Treatments for Pulmonary Hypertension